"Mice" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The common name for the genus Mus.
| Descriptor ID |
D051379
|
| MeSH Number(s) |
B01.050.150.900.649.313.992.635.505.500
|
| Concept/Terms |
Mus musculus- Mus musculus
- Mice, House
- House Mice
- Mouse, House
- House Mouse
Mus domesticus- Mus domesticus
- Mus musculus domesticus
- domesticus, Mus musculus
Mice, Laboratory- Mice, Laboratory
- Laboratory Mice
- Mouse, Laboratory
- Laboratory Mouse
|
Below are MeSH descriptors whose meaning is more general than "Mice".
Below are MeSH descriptors whose meaning is more specific than "Mice".
This graph shows the total number of publications written about "Mice" by people in this website by year, and whether "Mice" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 125 | 130 |
| 1996 | 1 | 138 | 139 |
| 1997 | 1 | 146 | 147 |
| 1998 | 2 | 151 | 153 |
| 1999 | 1 | 192 | 193 |
| 2000 | 1 | 237 | 238 |
| 2001 | 2 | 201 | 203 |
| 2002 | 5 | 296 | 301 |
| 2003 | 2 | 320 | 322 |
| 2004 | 2 | 313 | 315 |
| 2005 | 2 | 296 | 298 |
| 2006 | 5 | 357 | 362 |
| 2007 | 2 | 375 | 377 |
| 2008 | 0 | 379 | 379 |
| 2009 | 3 | 437 | 440 |
| 2010 | 3 | 484 | 487 |
| 2011 | 3 | 530 | 533 |
| 2012 | 2 | 494 | 496 |
| 2013 | 0 | 550 | 550 |
| 2014 | 2 | 511 | 513 |
| 2015 | 0 | 488 | 488 |
| 2016 | 1 | 480 | 481 |
| 2017 | 1 | 452 | 453 |
| 2018 | 3 | 500 | 503 |
| 2019 | 1 | 488 | 489 |
| 2020 | 1 | 574 | 575 |
| 2021 | 0 | 531 | 531 |
| 2022 | 0 | 446 | 446 |
| 2023 | 0 | 435 | 435 |
| 2024 | 0 | 455 | 455 |
| 2025 | 0 | 356 | 356 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice" by people in Profiles.
-
Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase. Blood Adv. 2025 Nov 11; 9(21):5598-5609.
-
Mutant p53 variants differentially impact replication initiation and activate cGAS-STING to affect immune checkpoint inhibition. Commun Biol. 2025 Nov 05; 8(1):1522.
-
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Na?ve and Longitudinal Samples during Neoadjuvant Chemotherapy. Cancer Res. 2025 Nov 03; 85(21):4062-4080.
-
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer. Cancer Discov. 2025 Nov 03; 15(11):2326-2343.
-
Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b. Cancer Immunol Res. 2025 Nov 03; 13(11):1732-1748.
-
Ovarian SUMO-2/3 targets and their differential response to genotoxic stress induced by 7,12-dimethylbenz(a) anthracene exposure in lean and obese female mice?. Biol Reprod. 2025 Oct 14; 113(4):962-976.
-
Antibiotic treatment limits survival of peripheral and bone marrow B-cell populations. Blood Adv. 2025 Oct 14; 9(19):5056-5069.
-
Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas. Cancer Immunol Res. 2025 Oct 01; 13(10):1591-1608.
-
TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength. Cancer Immunol Res. 2025 Oct 01; 13(10):1576-1590.
-
Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2025 Oct 01; 31(19):4184-4195.